Topical pharmacotherapies offer the unique advantage that the products are applied directly to the diseased skin, resulting in local, distinctly direct contact between the product and the affected skin. The choice of vehicle depends on the type of dermatosis. Vehicle polarity and vehicle viscosity result in optimal contact between the vehicle and affected skin, allowing uncomplicated application and distribution of the product.
Autoren
- Prof. Dr. phil. nat. Christian Surber
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- From symptom to diagnosis
Multilocular cystic renal cell carcinoma (MCRCC)
- Shaping the Future with LLM & Co.
AI in Everyday Clinical Practice: Friend or Foe?
- Ulcerative colitis: current evidence on anti-inflammatory therapies
Remission induction and maintenance with biologics and JAK-i
- Bronchiectasis
New strategies against neutrophilic inflammation
- IBD in childhood
Pneumococcal vaccination without negative consequences
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- Seborrheic Dermatitis in Adults and Adolescents
Current State of Knowledge and New Therapeutic Approaches
- Orthobiologics for knee osteoarthritis